Mycobacterium fortuitum keratitis.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003315:Cornea; D004487:Edema / Q000209:etiology; D005129:Eye Foreign Bodies / Q000150:complications; D006801:Humans; D007634:Keratitis / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D009161:Mycobacterium / Q000187:drug effects / Q000302:isolation & purification; D009164:Mycobacterium Infections / Q000150:complications* / Q000188:drug therapy; D009883:Ophthalmic Solutions; D009887:Ophthalmoscopy; D012293:Rifampin / Q000627:therapeutic use; D013045:Species Specificity; D014792:Visual Acuity
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D009883:Ophthalmic Solutions; D012293:Rifampin